Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases

NCT06316076 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Systemic Lupus Erythematosus
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Idiopathic Inflammatory Myopathies
Systemic Sclerosis

Interventions

BIOLOGICAL: CD19-CAR-DNT cells

Sponsor

RenJi Hospital

Collaborators

[object Object]